Snakes and ladders - Taipan venom in the fight against heart failure

A venom compound from the world’s deadliest snake, the Taipan, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure.
Congestive heart failure (CHF) claims the lives of over 3,000 Australians each year with a further 300,000 people affected by the disease.
The project’s principal researcher, University of Queensland’s Institute for Molecular Bioscience’s Professor Paul Alewood, said current treatments for CHF had serious side effects and rarely combated the progression of the disease.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news2174.html">Snakes and ladders - Taipan venom in the fight against heart failure</a></p> <p>A venom compound from the world’s deadliest snake, the Taipan, is being developed by Brisbane biotechnology company ElaCor, as a new drug to treat heart failure. <br>Congestive heart failure (CHF) claims the lives of over 3,000 Australians each year with a further 300,000 people affected by the disease. <br>The project’s principal researcher, University of Queensland’s Institute for Molecular Bioscience’s Professor Paul Alewood, said current treatments for CHF had serious side effects and rarely combated the progression of the disease. </p>